SYSTEM AND METHOD FOR INJECTING CONTRAST PRODUCTS

• US 20100030070A1
• Filed: 06/13/2007
• Published: 02/04/2010
• Est. Priority Date: 06/16/2006
• Status: Abandoned Application

• Current Assignee: Swiss Medical Care
• Original Assignee: Swiss Medical Care
• Inventors: Duffour, Hervé, Neftel, Frédéric
• Application Number:
  US12/304,207
• Publication Number:
  US 20100030070A1
• Time in Patent Office: Days
• US Class Current: 600/431
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 5/007 for contrast media
• CPC Class Codes: A61M 5/1408 in parallel, e.g. manifolds, sequencing valves access sites A61M39/02; tube connectors A61M39/10

Abstract

The invention concerns a system for injecting contrast product comprising an injecting mechanism, at least two reservoirs operatively associated with the injecting mechanism, said reservoirs being designed to contain at least one contrast product and one rinsing product respectively; and a control device comprising programming means, which is operatively associated with the injecting mechanism and capable of operating for programming selectively one or more injection process phases. The system is characterized in that it comprises a triggering member operatively associated with the control device so that the control device is capable of programming at least one injecting phase of the contrast product at a predetermined flow rate followed by a rinsing phase at another predetermined flow rate and a programmed duration for injecting the contrast product based on a signal given during the injection by said triggering member when the contrast product is visualized in a region of interest. The invention also concerns a method for using said system as well as various applications thereof.

Claims

1. A system for injecting contrast products comprising an imaging device suitable for viewing a contrast product in an area of interest, an injection mechanism, at least two reservoirs operatively associated with said injection mechanism, said reservoirs being designed to contain respectively at least one contrast product and one rinsing product;

a control device, comprising programming means, which is operatively associated with the injection mechanism and capable of operating to selectively program one or more injection procedure phases;

the system being characterized in that it comprises a triggering member operatively associated with the control device and with the imaging device, said triggering member being designed to be activated when the contrast product is viewed in a region of interest.

2. The system as claimed in claim 1, comprising means for programming an image acquisition time from the activation of the triggering member.

3. The system as claimed in claim 2, comprising processing means which, during the image acquisition time, incorporate any time needed to reposition the imaging appliance before the start of image acquisitions to calculate the injection time.

4. The system as claimed in claim 1, in which the triggering member is designed to be activated manually.

5. The system as claimed in claim 1, in which the triggering member is designed to be activated automatically.

6. The system as claimed in claim 5, characterized in that it can be activated directly by the imaging device.

7. The system as claimed in claim 1, comprising security means which are designed to limit a maximum injection volume of contrast product during a phase, said maximum volume preferably being defined according to the patient.

8. A method using a system as defined in claim 1, for the injection of contrast products and the acquisition of images, said method being characterized in that it comprises at least one phase of contrast product injection at a determined flow rate, without either the volume or the time being determined in advance, followed by a rinsing phase at another determined flow rate, the injection time of the contrast product being dependent on a signal given during the injection by the triggering member when the contrast product is viewed in a region of interest, in order to make it possible to acquire contrasted images in an area called “

image acquisition area”

.

9. The method as claimed in claim 1, characterized in that the initiation of the triggering member also initiates an image acquisition process, said initiation being performed manually or automatically.

10. The method as claimed in claim 8, in which the injection time of the contrast product from the triggering signal is dependent on the time needed for the presence of contrast product in said image acquisition area, said injection time being calculated according to the image acquisition time.

11. The method as claimed in claim 10, in which account is taken of the volume of buffer contrast product situated in the vascular system of the patient (between the injection point and the area of interest), this volume being deduced by analysis of the time needed for the contrast product to appear in the area of interest from the start of the injection, in order to minimize the volume of contrast product injected into the patient because of the use of at least a part of this volume of buffer contrast product which will be pushed by the rinsing product before the end of the acquisition sequence in such a way that contrast product is present in the area that has to be examined throughout the duration of the acquisition sequence.

12. The method as claimed in claim 11, in which the rinsing product is injected at the earliest Tr seconds before the end of the acquisition sequence, Tr representing the time between the start of the injection of contrast product and the signal, in order to ensure that there is no rinsing product in the area situated downstream of the area of interest throughout the acquisition.

13. The method as claimed in claim 11, in which the rinsing product is injected early enough after the triggering of the signal in order to ensure that a certain territory situated upstream of the area of interest contains a low level of contrast product, but late enough to ensure that the part of the acquisition area which is situated downstream of the image acquisition area contains a sufficiently high level of contrast product throughout the acquisition.

14. The method as claimed in any claim 10, in which the flow rate of the rinsing product is identical to that of the contrast product at least throughout the remaining time of the acquisition sequence, the injection of the rinsing product being advanced by a time that is at most equal to that defined between the start of the injection of contrast product and the instant at which the signal has been triggered.

15. The method as claimed in claim 8, in which the flow rate of the rinsing product is reduced after the end of the image acquisition sequence.

16. The method as claimed in claim 15, in which the reduction is gradual.

17. The method as claimed in claim 8, in which the total volume of rinsing product injected is programmed initially.

18. The method as claimed claim 8, in which the total volume of rinsing product injected is calculated according to preprogrammed parameters.

19. The use of a system as claimed in claim 1, characterized in that the triggering member is activated manually or automatically at the moment when the contrast product is viewed in the area of interest.

20. The use of a system as claimed in claim 1 for imaging by CT scanner.

21. The use of a system as claimed claim 1 for angiography CT imaging procedures.

22. The use as claimed in claim 21, in which the acquisition sequence corresponds to that of the images of the heart.

23. The use as claimed in claim 22, in which the signal is given when the contrast product appears in a region situated at the output of the left ventricle.

24. The use as claimed in claim 20, in which the rinsing sequence is determined so as to guarantee a certain concentration of contrast product present in the right heart during the acquisition phase which is less than a determined threshold.

25. The use as claimed in claim 24, in which the quantity of contrast product in the right heart is minimized.

26. The use of a system as claimed in claim 1 for imaging the lung.

27. The use as claimed in claim 26, in which the area of interest is situated in an area at the output of the right ventricle.

28. The use as claimed in claim 26, in which the progression of the appearance of the rinsing product in the lung is calculated precisely according to the acquisition sequence.